Table 1 Statistics of clinical characteristics and laboratory indexes of the study cohort

From: Novel therapeutic evaluation biomarkers of lipid metabolism targets in uncomplicated pulmonary tuberculosis patients

 

Healthy controls

Untreated TB

2 Months

6 Months

 
 

(N = 30)

(N = 30)

(N = 30)

(N = 30)

P value

Age (median, IQR)

33.5 (27.7–47.7)

32.0 (22.7–54.0)

32.0 (25.7–45.7)

34.0 (25.2–47.5)

0.924a

BMI (median, IQR)

21.1 (20.0–22.3)

20.2 (16.4–24.0)

20.9 (19.0–21.6)

20.9 (18.2–24.4)

0.849a

Gender (male)

17 (56%)

13 (43%)

18 (60%)

20 (67%)

0.317b

Sputum smear: positive, no. (%)

/

16 (53%)

14 (47%)

14 (47%)

0.837b

Xpert MTB/RIF: positive, no. (%)

/

20 (67%)

19 (63%)

19 (63%)

0.953b

PCR chip: positive, no. (%)

/

10 (33%)

12 (40%)

16 (53%)

0.279b

Cultivate: positive, no. (%)

/

16 (53%)

16 (53%)

16 (53%)

1.000b

T-spot.TB: positive, no. (%)

/

20 (67%)

19 (63%)

20 (67%)

0.952b

  1. N number of subjects, TB0 untreated TB patients, TB2 2-month-treated TB patients, TB6 cured TB subjects, HC health controls
  2. aP value among four groups from Kruskal–Wallis H test
  3. bP value among four groups from the Chi-square test
Back to article page